Image

Bridging the Gap: Educating Patients on Social Determinants of Health to Improve Epilepsy Surgery Access and Outcomes

Bridging the Gap: Educating Patients on Social Determinants of Health to Improve Epilepsy Surgery Access and Outcomes

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this study is to identify the needs and barriers to accessing and undergoing epilepsy surgery for patients with epilepsy and then to pilot an educational program regarding the social determinants of health and how they can influence surgical rates and epilepsy outcomes.

For the first part, patients (age 18+) and providers will be asked to complete surveys and participate in focus groups to identify gaps and barriers that limit access to and use of epilepsy surgery.

For piloting the education program, patients (age 18+) at the Cleveland Clinic Epilepsy Monitoring Unit will be randomized to intervention or control. Those in the intervention group, in addition to their usual care, will also receive educational materials on social determinants of health and their influence on surgical rates and epilepsy outcomes. Those in the control group will receive their usual care. Both groups will be asked to fill out surveys and questionnaires at the beginning of their stay, at the end of their stay, and if they elect to have surgery, 12 months after surgery.

Eligibility

Inclusion Criteria:

  • Part 1:
  • Epilepsy diagnosis
  • Completion of epilepsy surgical evaluation at Cleveland Clinic
  • Recommendation for resective/ablation surgery or implantation of neurostimulation device
  • At least 18 years old
  • Part 2a - Patient survey:
  • At least 18 years old
  • Epilepsy diagnosis
  • Evaluated for epilepsy surgery
  • English proficiency enough to complete survey
  • Part 2a - Provider survey:
  • Healthcare professional in the US who is involved in the clinical care or treatment of individuals with epilepsy
  • Part 2b - Cleveland Clinic patient focus groups:
  • Epilepsy diagnosis
  • Previously completed epilepsy workup at Cleveland Clinic
  • At least 18 years old
  • Has Basic Interpersonal Fluency Skills in English (based on phone interview)
  • Has no evidence of dementia or intellectual disability that would interfere with participation in the focus group
  • Part 2b - Cleveland Clinic provider focus groups:
  • Clinicians that are members of Cleveland Clinic Epilepsy Center and provide care to patients with epilepsy
  • Part 2b - Community patient focus groups:
  • Epilepsy diagnosis
  • Previously completed epilepsy workup
  • At least 18 years old
  • Has Basic Interpersonal Fluency Skills in English (based on phone interview)
  • Part 2b - Community provider focus groups:
  • Clinician that provides care to patients with epilepsy outside of Cleveland Clinic
  • Part 3:
  • At least 18 years old
  • Fluent in English
  • Being evaluated for epilepsy surgery at the Cleveland Clinic Epilepsy Monitoring Unit

Exclusion Criteria:

  • Part 1:
  • Previous epilepsy surgery or implantation of neurostimulation device
  • Part 2a - Patient survey:
  • Unable to fluently read English
  • Has evidence of dementia or intellectual disability that would interfere with patient's understanding of surveys
  • Part 2a - Provider survey:
  • Unable to fluently read English
  • Part 2b - Cleveland Clinic patient focus groups:
  • Is not fluent in English
  • Has evidence of dementia or intellectual disability that would interfere with patient's understanding of or ability to participate in the focus group
  • Has had prior epilepsy surgery
  • Part 2b - Cleveland Clinic provider focus groups:
  • Clinicians involved in the development of the study design
  • Part 2b - Community patient focus groups:
  • Is not fluent in English
  • Has evidence of dementia or intellectual disability that would interfere with patient's understanding of or ability to participate in the focus group
  • Has had prior epilepsy surgery
  • Part 3:
  • Is not fluent in English
  • Evidence of dementia or intellectual disability that would interfere with patient's understanding of intervention

Study details
    Epilepsy

NCT07509190

Anny Reyes

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.